103 results
management diagnosis treatment pharmacology infections idsa opportunistic algorithm nephrology hepatology neurology differential endocrinology syndrome criteria oncology dka hypomagnesemia diabetes dosing
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... PO (or 400 mg IV ... Bacterial #IDSA #Prevention ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... Itraconazolea 200 mg ... itraconazolea 200 mg ... opportunistic #infections #HIVAIDS
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Scoring System CRP (mg/dL), WBC (per mm3), Hemoglobin (g/dL),
Scoring System CRP (mg ... /dL), WBC (per ... , Creatinine (mg ... /dL), Glucose ... (mg/dL), Score
Ranson's Criteria in Pancreatitis At Admission: - Age > 55 years - WBCs >
Glucose > 200 mg ... /dl - LDH > 350 ... - BUN rise > 5 mg ... /dl - Calcium ... < 8 mg/dl -
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
Recommendations for Preventing ... ) in HIV-AIDS Preventing ... Benznidazole 5–8 mg ... Nifurtimox 8–10 mg ... opportunistic #infections #HIVAIDS
Acute Kidney Injury - RIFLE and AKIN Criteria for Diagnosis and Classification of AKI • AKIN
Increase in SCr ≥ 0.3 mg ... /dL or increase ... /dL with an acute ... increase of ≥ 0.5 mg ... /dL; or on RRT
Classification of Tumor Lysis Syndrome (TLS) and Treatment of Metabolic Abnormalities of TLS Laboratory TLS: • Uric
Uric acid ≥ 8.0 mg ... /dL • Potassium ... ≥ 6.0 mEq/dL ... Phosphorus ≥ 4.6 mg ... ≤ 7.0 mg/dL Clinical
Multiple Myeloma and Monoclonal Gammopathies C - HyperCalcemia- calcium > 11 mg/dL / >1 mg/dL the ULN R
- calcium > 11 mg ... /dL / >1 mg/dL the ... disease - Cr >2 mg ... /dL or CC < 40 ml ... or <2 g/dl LLN
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
amphotericin B 2–4 mg ... schedule (e.g., 4 mg ... dose of 20–60 mg ... Leishmaniasis #Prevention ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
Fluconazole 100 mg ... buccal tablet 50 mg ... suspension 400 mg ... mucosal #IDSA #Prevention ... opportunistic #infections #HIVAIDS
No results found for "mg/dL prevention hivaids"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #mg/dL #prevention #hivaids